Constitutional asymmetry and pharmaceutical policy-making in the European Union

References

• Abraham , J. and Lewis , G. 2000 . Regulating Medicines in Europe: Competition, Expertise and Public Health , London : Routledge .
   Google Scholar
• Albedo . 1991 . Transparency Directive II – sequel or remake? . Pharmaceutical Technology Europe , September : 12 – 20 .
   Google Scholar
• BEUC . 1991 . “ ‘Longer patent protection periods for medicines: a blank cheque for the pharmaceutical industry?’, BEUC press release ” . Brussels : Bureau Européen des Unions de Consommateurs .
   Google Scholar
• BEUC . 1994 . BEUC's Opinion on the Outlines of an Industrial Policy for the Pharmaceutical Sector in the EC , Brussels : Bureau Européen des Unions de Consommateurs .
   Google Scholar
• Brittan , L. Making a reality of the Single Market: pharmaceutical pricing and the European Economic Community . Speech to the Institute of Economic Affairs Conference on Pharmaceutical Policies in Europ . December 1992 , London .
   Google Scholar
• Cameron , McKenna . 2000 . Evaluation of the Operation of Community Procedures for the Authorization of Medicinal Products – Report Carried Out on Behalf of the European Commission , Brussels : DG Enterprise, Commission of the European Communities .
   Google Scholar
• CEC (1988) . " Memorandum III/3785/88 ." Compilation of Comments Received on Outstanding White Paper Proposals for Completion of the Internal Market in the Pharmaceutical Sector. , Commission of the European Communities Brussels
   Google Scholar
• CEC (1990) . " Proposal for a Council Regulation (EEC) Laying Down Community Procedures for the Authorization and Supervision of Medicinal Products for Human and Veterinary Use and Establishing a European Agency for the Evaluation of Medicinal Products ." Official Journal of the European Communities , COM (1990) 283 Final – SYN 309 . 14 November 1990, C330/90: 1
   Google Scholar
• CEC (1993) . " Commission of the European Communities ." Background Report: The European Medicines Evaluation Agency. , ISEC/B33/93 .
   Google Scholar
• CEC (1995) . " Inauguration of the European Agency for the Evaluation of Medicinal Products ." press release DN: IP/95/64, 1995-01-26 . Commission of the European Communities Brussels
   Google Scholar
• CECG . 1993 . Pharmaceuticals in the Single Market , Consumers in the European Community Group .
   Google Scholar
• Chapman , S. , Durieux , P. and Walley , T. 2004 . “ Good prescribing practice ” . In Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality , Edited by: Mossialos , E. , Mrazek , M. and Walley , T. Maidenhead : Open University Press .
   Google Scholar
• COM (1993) . " Commission Communication to the Council and Parliament on the outlines of an industrial policy for the pharmaceutical sector in the European Community ." COM (93) 718 . 2 March 1994
   Google Scholar
• COM (2001) . " Proposal for a Regulation of the European Parliament and of the Council Laying Down Community Procedures for the Authorization and Supervision of Medicinal Products for Human and Veterinary Use and Establishing a European Agency for the Evaluation of Medicinal Products ." COM /2001/0404 final .
   Google Scholar
• COM (2003) . " Communication from the Commission to the Council, European Parliament, the Economic and Social Committee, and the Committee of the Regions: A Stronger European-based Pharmaceutical Industry for the Benefit of the Patient – A Call for Action ." 383 Final of 1 July 2003 .
   Google Scholar
• EFPIA . 2002 . The Pharmaceutical Industry in Figures – Key Data (2002 Update) , Brussels : European Federation of Pharmaceutical Industries and Associations .
   Google Scholar
• EMEA (1996) . " First General Report on the Activities of the European Agency for the Evaluation of Medicinal Products 1995 ." EMEA/MB/065/95 .
   Google Scholar
• Furniss , J. 1997 . The Bangemann round table: a beginning and not an end . Eurohealth , 3 ( 1 ) : 27 – 8 .
   Google Scholar
• G10 (2002) . " High Level Group on Innovation and Provision of Medicines: recommendations for action, Enterprise Directorate-General ." Commission of the European Communities Brussels
   Google Scholar
• Garattini , S. and Bertele' , V. 2001 . “ Adjusting Europe's drug regulation to public health needs ” . In The Lancet Vol. 358 , 64 – 7 .
   Google Scholar
• Generics Bulletin . 2004 . European revisions offer new freedoms for generics . 16 January 2004 : 18 – 21 .
   Google Scholar
• Hancher , L. 1990 . The European pharmaceutical market: problems of partial harmonization . European Law Review , 15 : 9 – 33 .
   Google Scholar
• Hood , C. 1994 . Explaining Economic Policy Reversals , Buckingham : Open University Press .
   Google Scholar
• Majone , G. 1996 . Regulating Europe , Edited by: Majone , G. London : Routledge .
   Google Scholar
• Matthews , D. and Wilson , C. 1998 . Pharmaceutical regulation in the single European market . Medicine and Law , 17 : 401 – 27 .
   PubMedGoogle Scholar
• Orzack , L. 1996 . Professionals, consumers, and the European medicines agency: policy-making in the European Union . Current Research on Occupations and Professions , 9 : 9 – 29 .
   Google Scholar
• Permanand , G. 2002 . “ Regulating under constraint: the case of EU pharmaceutical policy ” . University of London: London School of Economics and Political Science . Ph.D. dissertation
   Google Scholar
• Permanand , G. and Altenstetter , C. 2004 . “ The politics of pharmaceuticals in the European Union ” . In Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity and Quality , Edited by: Mossialos , E. , Mrazek , M. and Walley , T. Maidenhead : Open University Press .
   Google Scholar
• PhRMA . 2002 . PhRMA Industry Profile 2002 , Washington , DC : Pharmaceutical Research and Manufacturers of America .
   Google Scholar
• Sauer , F. 13 November 2000 2000 . “ New drugs in the global economy ” . 13 November 2000 , University of Pittsburgh . Speech to the Graduate School of Public Health
   Google Scholar
• Scharpf , F. 2002 . “ Max-Planck-Institut für Gesellschaftsforschung Working Paper 02/08 ” . In The European Social Model: Coping with the Challenges of Diversity , Köln : MPIfG .
   Google Scholar
• Scherer , F. 1996 . Industry Structure, Strategy, and Public Policy , New York : HarperCollins College Publishers .
   Google Scholar
• Shechter , Y. 1998 . “ Interests, strategies, and institutions: lobbying in the pharmaceutical industry of the European Union ” . University of London: London School of Economics and Political Science . Ph.D. dissertation
   Google Scholar
• Weiler , J. 1994 . A quiet revolution: the European Court of Justice and its interlocutors . Comparative Political Studies , 26 : 510 – 34 .
   Web of Science ®Google Scholar
• Wilson , J. 1980 . “ The politics of regulation ” . In The Politics of Regulation , Edited by: Wilson , J.Q . New York : Basic Books Inc .
   Google Scholar